CIBC Private Wealth Group
OCUL icon

CIBC Private Wealth Group’s Ocular Therapeutix OCUL Stock Holding History

CIBC Private Wealth Group’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$97.6K Hold
8,040
– – ﹤0.01% 1527
2025
Q3 		$94K Hold
8,040
– – ﹤0.01% 1523
2025
Q2 		$74.6K Hold
8,040
– – ﹤0.01% 1516
2025
Q1 		$48.4K Hold
8,040
– – ﹤0.01% 1638
2024
Q4 		$71.3K Hold
8,040
– – ﹤0.01% 1545
2024
Q3 		$69.9K Hold
8,040
– – ﹤0.01% 1649
2024
Q2 		$53.5K Hold
8,040
– – ﹤0.01% 1652
2024
Q1 		$69.9K Buy
+8,040
New +$57.1K ﹤0.01% 1531
2022
Q4 		– Sell
-11,409
Closed -$47K – 918
2022
Q3 		$47K Sell
11,409
-3,368
-23% -$17K ﹤0.01% 891
2022
Q2 		$59K Hold
14,777
– – ﹤0.01% 957
2022
Q1 		$73K Buy
14,777
+2,737
+23% +$15.2K ﹤0.01% 1013
2021
Q4 		$84K Hold
12,040
– – ﹤0.01% 995
2021
Q3 		$120K Hold
12,040
– – ﹤0.01% 912
2021
Q2 		$171K Hold
12,040
– – ﹤0.01% 1004
2021
Q1 		$198K Hold
12,040
– – ﹤0.01% 998
2020
Q4 		$249K Buy
12,040
+1,000
+9% +$14.9K ﹤0.01% 906
2020
Q3 		$84K Buy
+11,040
New +$91.6K ﹤0.01% 860
2018
Q3 		– Sell
-1,000
Closed -$7K – 1466
2018
Q2 		$7K Hold
1,000
– – ﹤0.01% 1654
2018
Q1 		$7K Hold
1,000
– – ﹤0.01% 1599
2017
Q4 		$4K Buy
+1,000
New +$5.11K ﹤0.01% 1731

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Private Wealth Group's OCUL Position: Q4 2025 in Review

CIBC Private Wealth Group held its Ocular Therapeutix (OCUL) position steady in Q4 2025 at 8,040 shares worth $97.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

CIBC Private Wealth Group first reported a position in OCUL in Q4 2017 and has held it in 20 quarters since. The position peaked at $249K in Q4 2020. 249 funds tracked by Wall St. Rank hold OCUL as of Q4 2025.

  • CIBC Private Wealth Group held 8,040 shares of Ocular Therapeutix worth $97.6K as of Q4 2025.
  • CIBC Private Wealth Group left its Ocular Therapeutix share count unchanged in Q4 2025.
  • Ocular Therapeutix made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1527 holding.
  • CIBC Private Wealth Group first reported a position in Ocular Therapeutix in Q4 2017 and has held it in 20 quarters since.
  • CIBC Private Wealth Group's Ocular Therapeutix position peaked at $249K in Q4 2020.
  • 249 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.